Major Cancer Meeting Highlights Practice-Changing Cancer Studies
Main Category: Lung CancerAlso Included In: Conferences; Breast Cancer; Prostate / Prostate Cancer
Article Date: 30 Oct 2009 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
4 news briefings with live webcast previewing studies
The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.
News briefing 1
When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
- Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).
- Additional, specialized radiation not necessary for some women after mastectomy.
- Radiation after surgery reduces chance of melanoma returning.
- What are the real benefits versus risks of preventative brain radiation for patients with non-small cell lung cancer?
News briefing 2
When: Monday, November 2, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
- Stereotactic radiotherapy stops lung cancer from growing in frail patients.
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients.
News briefing 3
When: Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
- Adding proton therapy "boost" to X-ray radiation therapy reduces prostate cancer recurrences.
- Proton therapy is well-tolerated in prostate cancer patients.
News briefing 4
When: Tuesday, November 3, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
- Shorter radiation course stops cancer growth in high-risk prostate cancer patients.
- Shorter radiation course as effective as standard therapy for prostate cancer recurrence.
How: To participate in the webcasts, click on the links above to view slides and listen to the audio of the conference live over the Internet.
Source: Beth Bukata
American Society for Radiation Oncology
Visit our lung cancer section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/169312.php>
APA
http://www.medicalnewstoday.com/releases/169312.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




